Literature DB >> 25877370

Genetical study of mutation in maternal-fetal ABO incompatibility.

Zhong-Qing Yu1, Feng-Lan Hu2, Qiong Cheng2, Jian-Hua Hao2, Jian-Hua Zhang2, Xue-Na Lin2, Bao Zheng2, Ping-Ping Fa2, Su-Yan Yu2, Li-Hua Hu3.   

Abstract

This study looked into a family involving a rare mother-child ABO blood type inconsistency and explored its genetic and molecular basis. In the family, the mother had type AB blood and the father was blood type B and they gave birth to a baby of blood type O. Their blood types were phenotypically identified by using different techniques, including micro-column gel test, immune inhibition test, absorption and elution tests. The sequences of all 7 exons of ABO allele from the core family members were determined by using PCR and clone-based sequencing. The loci of mutated gene were compared against normal human genes. The result showed that the mother's erythrocytes were agglutinable with monoclonal anti-A antibody (2+) and had agglutination reaction with anti-B antibody (4+). The mother's serum registered agglutination action with standard blood type A cells. The findings showed an ABO inconsistency. When domestic antibodies were used, the mother's erythrocytes yielded agglutination reaction with humanized anti-B serum (4+) and anti-B monoclonal antibody but were non-agglutinable with humanized anti-A serum and anti-A monoclonal antibody. Upon absorption and elution, the titer of anit-A antibody was 128 both before and after the absorption test, with no significant difference found between pre- and post-absorption values. Our results confirmed that the mother's allelic gene was type B and contained type A. The father's blood type was type B, and son's blood type was type O. Clone-based sequencing revealed that the mother carried a heterozygous gene of B101.01 (ntA640→G)/O01, which contained an M214→V mutation that could express a weak expression of antigen A, resulting in blood type AB. However, their son did not have the M214→V mutation, which yielded a false ABO-inconsistency between him and his mother. We were led to conclude that type B gene with a M214→V mutation can encode both antigen B and weak antigen B that can lead to false ABO-inconsistencies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25877370     DOI: 10.1007/s11596-015-1429-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Characterization of a novel B(A) allele with BBBA type at the ABO blood group.

Authors:  Zhi-Hui Deng; Qiong Yu; Yan-Lian Liang; Da-Ming Wang; Yu-Qing Su; Guo-Guang Wu
Journal:  J Hum Genet       Date:  2006-07-27       Impact factor: 3.172

2.  Identification of a subset of group B donors reactive with monoclonal anti-A reagent.

Authors:  M L Beck; A D Yates; J Hardman; M A Kowalski
Journal:  Am J Clin Pathol       Date:  1989-11       Impact factor: 2.493

3.  Molecular genetic analysis of the ABO blood group system: 2. cis-AB alleles.

Authors:  F Yamamoto; P D McNeill; Y Kominato; M Yamamoto; S Hakomori; S Ishimoto; S Nishida; M Shima; Y Fujimura
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

4.  Systematic analysis of the ABO gene diversity within exons 6 and 7 by PCR screening reveals new ABO alleles.

Authors:  Axel Seltsam; Michael Hallensleben; Anke Kollmann; Jürgen Burkhart; Rainer Blasczyk
Journal:  Transfusion       Date:  2003-04       Impact factor: 3.157

5.  Molecular genetic analysis for Ax phenotype of the ABO blood group system in Chinese.

Authors:  Z H Deng; Q Yu; G G Wu; Y L Lian; Y Q Su; D C Li; D M Wang; S Y Zhang
Journal:  Vox Sang       Date:  2005-11       Impact factor: 2.144

6.  Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?

Authors:  Cesar Homero Gutiérrez-Aguirre; Andrés Gómez-De-León; Julio Alatorre-Ricardo; Olga Graciela Cantú-Rodríguez; Oscar González-Llano; José Carlos Jaime-Pérez; Consuelo Mancías-Guerra; Juan Antonio Flores-Jiménez; David Gómez-Almaguer
Journal:  Transfusion       Date:  2013-10-28       Impact factor: 3.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.